EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities

Harshita Tiwari, Swati Singh, Sonal Sharma, Priyamvada Gupta, Ashish Verma, Amrit Chattopadhaya, Brijesh Kumar, Sakshi Agarwal, Rajiv Kumar iD, Sanjeev Kumar Gupta, Vibhav Gautam iD

Medicinal Research Reviews · 2025-05 · 45 (3) · 817-841

DOI: 10.1002/med.22090 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 24.10.2024. Verfasst von Harshita Tiwari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Tumor Microenvironment, Biomarkers, Tumor. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 155 Literaturangaben. Gefördert von: University Grants Commission, Banaras Hindu University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple negative breast cancer (TNBC) displays a notable challenge in clinical oncology due to its invasive nature which is attributed to the absence of progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor receptor (HER‐2). The heterogenous tumor microenvironment (TME) of TNBC is composed of diverse constituents that intricately interact to evade immune response and facilitate cancer progression and metastasis. Based on molecular gene expression, TNBC is classified into four molecular subtypes: basal‐like (BL1 and BL2), luminal androgen receptor (LAR), immunomodulatory (IM), and mesenchymal. TNBC is an aggressive histological variant with adverse prognosis and poor therapeutic response. The lack of response in most of the TNBC patients could be attributed to the heterogeneity of the disease, highlighting the need for more effective treatments and reliable prognostic biomarkers. Targeting certain signaling pathways and their components has emerged as a promising therapeutic strategy for improving patient outcomes. In this review, we have summarized the interactions among various components of the dynamic TME in TNBC and discussed the classification of its molecular subtypes. Moreover, the purpose of this review is to compile and provide an overview of the most recent data about recently discovered novel TNBC biomarkers and targeted therapeutics that have proven successful in treating metastatic TNBC. The emergence of novel therapeutic strategies such as chemoimmunotherapy, chimeric antigen receptor (CAR)‐T cells‐based immunotherapy, phytometabolites‐mediated natural therapy, photodynamic and photothermal approaches have made a significant positive impact and have paved the way for more effective interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsTumor MicroenvironmentBiomarkers, TumorHumansFemaleAnimals

Stichwörter der Autor:innen

CAR‐T cellsTNBCchemoimmunotherapyoncogenic signalingprognostic biomarkers

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
  • Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
  • Department of Biomedical Engineering, Indian Institute of Technology, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
  • Department of Obstetrics and Gynaecology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.

ORCID-Profile: Rajiv Kumar, Vibhav Gautam

Förderung

  • University Grants Commission
  • Banaras Hindu University

Zitieren

APA

Tiwari, H., Singh, S., Sharma, S., Gupta, P., Verma, A., Chattopadhaya, A., Kumar, B., Agarwal, S., Kumar, R., Gupta, S. K., & Gautam, V. (2025). Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities. Medicinal Research Reviews, 45(3), 817-841. https://doi.org/10.1002/med.22090

Vancouver

Tiwari H, Singh S, Sharma S, Gupta P, Verma A, Chattopadhaya A, et al. Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities. Medicinal Research Reviews. 2025;45(3):817-841. doi:10.1002/med.22090

BibTeX
@article{Tiwari2025,
  author = {Tiwari, Harshita and Singh, Swati and Sharma, Sonal and Gupta, Priyamvada and Verma, Ashish and Chattopadhaya, Amrit and Kumar, Brijesh and Agarwal, Sakshi and Kumar, Rajiv and Gupta, Sanjeev Kumar and Gautam, Vibhav},
  title = {Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities},
  journal = {Medicinal Research Reviews},
  year = {2025},
  volume = {45},
  number = {3},
  pages = {817--841},
  doi = {10.1002/med.22090}
}
Kostenlos starten →